Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
- PMID: 22102439
- PMCID: PMC3220620
- DOI: 10.1136/bmj.d6891
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Abstract
Objective: To evaluate the association between non-alcoholic fatty liver disease and all cause and cause specific mortality in a representative sample of the US general population.
Design: Prospective cohort study.
Setting: US Third National Health and Nutrition Examination Survey (NHANES III: 1988-94) with follow-up of mortality to 2006.
Participants: 11,371 adults aged 20-74 participating in the Third National Health and Nutrition Examination Survey, with assessment of hepatic steatosis.
Main outcome measure: Mortality from all causes, cardiovascular disease, cancer, and liver disease (up to 18 years of follow-up).
Results: The prevalence of non-alcoholic fatty liver disease with and without increased levels of liver enzymes in the population was 3.1% and 16.4%, respectively. Compared with participants without steatosis, those with non-alcoholic fatty liver disease but normal liver enzyme levels had multivariate adjusted hazard ratios for deaths from all causes of 0.92 (95% confidence interval 0.78 to 1.09), from cardiovascular disease of 0.86 (0.67 to 1.12), from cancer of 0.92 (0.67 to 1.27), and from liver disease of 0.64 (0.12 to 3.59). Compared with participants without steatosis, those with non-alcoholic fatty liver disease and increased liver enzyme levels had adjusted hazard ratios for deaths from all causes of 0.80 (0.52 to 1.22), from cardiovascular disease of 0.59 (0.29 to 1.20), from cancer of 0.53 (0.26 to 1.10), and from liver disease of 1.17 (0.15 to 8.93).
Conclusions: Non-alcoholic fatty liver disease was not associated with an increased risk of death from all causes, cardiovascular disease, cancer, or liver disease.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Comment in
-
Prognosis and staging of non-alcoholic fatty liver disease.BMJ. 2011 Nov 18;343:d7302. doi: 10.1136/bmj.d7302. BMJ. 2011. PMID: 22102440 No abstract available.
-
Mortality and non-alcoholic fatty liver disease: type of study cohort matters!Natl Med J India. 2012 Jan-Feb;25(1):28-30. Natl Med J India. 2012. PMID: 22680320 No abstract available.
-
Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition?Hepatology. 2012 Oct;56(4):1580-4. doi: 10.1002/hep.26031. Hepatology. 2012. PMID: 23038652 Free PMC article.
-
JPEN Journal Club 32. Adjusting for Confounding.JPEN J Parenter Enteral Nutr. 2018 Feb;42(2):473-476. doi: 10.1002/jpen.1052. Epub 2018 Jan 9. JPEN J Parenter Enteral Nutr. 2018. PMID: 29443398 No abstract available.
Similar articles
-
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.BMC Gastroenterol. 2019 Apr 16;19(1):56. doi: 10.1186/s12876-019-0972-6. BMC Gastroenterol. 2019. PMID: 30991959 Free PMC article.
-
Epidemiology of fatty liver: an update.World J Gastroenterol. 2014 Jul 21;20(27):9050-4. doi: 10.3748/wjg.v20.i27.9050. World J Gastroenterol. 2014. PMID: 25083078 Free PMC article. Review.
-
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.Metabolism. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. Epub 2012 Sep 19. Metabolism. 2013. PMID: 22999011
-
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30. Aliment Pharmacol Ther. 2011. PMID: 21623852 Review.
-
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.J Hepatol. 2008 Oct;49(4):608-12. doi: 10.1016/j.jhep.2008.06.018. Epub 2008 Jul 9. J Hepatol. 2008. PMID: 18682312
Cited by
-
Epidemiology of Hepatocellular Carcinoma in Taiwan.Clin Pract. 2024 Mar 28;14(2):570-578. doi: 10.3390/clinpract14020044. Clin Pract. 2024. PMID: 38666802 Free PMC article.
-
The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis.J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101277. doi: 10.1016/j.jceh.2023.08.013. Epub 2023 Sep 9. J Clin Exp Hepatol. 2024. PMID: 38076375
-
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023. Hepatol Forum. 2023. PMID: 37920782 Free PMC article.
-
Mechanisms Behind NAFLD: a System Genetics Perspective.Curr Atheroscler Rep. 2023 Nov;25(11):869-878. doi: 10.1007/s11883-023-01158-3. Epub 2023 Oct 9. Curr Atheroscler Rep. 2023. PMID: 37812367 Review.
-
Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor.Clin Exp Hepatol. 2023 Sep;9(3):187-192. doi: 10.5114/ceh.2023.130744. Epub 2023 Aug 28. Clin Exp Hepatol. 2023. PMID: 37790680 Free PMC article. Review.
References
-
- Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339-50. - PubMed
-
- Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-8. - PubMed
-
- Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-9. - PubMed
-
- Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-4. - PubMed
-
- Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042-7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical